Nestle India faces legal action as FSSAI flags baby food quality, promotion violations
FSSAI said a sample of follow-up formula manufactured by the company was found to be substandard with respect to biotin content during laboratory analysis.
The food safety regulator, FSSAI, has initiated legal action against Nestle India Ltd for quality and promotional violations related to baby food products. The regulator found that a baby food sample violated quality standards, specifically concerning biotin content. Additionally, FSSAI discovered that two other infant nutrition products—NAN Excella Pro Stage 1 and Lactogen Pro 1—were being promoted in contravention of regulations.
Nestle India responded by stating that its products comply with all applicable regulations and that the company will continue to cooperate with FSSAI. The company's shares experienced a temporary decline after the news but later recovered. In 2015, Nestle faced a significant regulatory issue when its Maggi noodles were banned due to high lead levels and labeling errors, resulting in a massive recall. However, Maggi was later reintroduced after additional testing.
Baby foods and milk products account for a significant portion of Nestle India's revenue, representing one-third of the company's product sales in the year ending March 2026, totaling $2.4 billion.
Written by urgent.news from Hindustan Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
